About Sealantis
Sealantis is a company based in Haifa (Israel) founded in 2007 was acquired by Advanced Medical Solutions in February 2019. Sealantis has raised $3 million across 1 funding round from investors including Advanced Medical Solutions and Teuza. Sealantis operates in a competitive market with competitors including Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
- Headquarter Haifa, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 1 rounds
-
Latest Funding Round
$3 M (USD), Series A
Feb 18, 2015
-
Investors
Advanced Medical Solutions
& 1 more
-
Employee Count
Not available
-
Acquired by
Advanced Medical Solutions
(Feb 01, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sealantis
Sealantis has successfully raised a total of $3M through 1 strategic funding round. The most recent funding activity was a Series A round of $3 million completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sealantis
Sealantis has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Advanced Medical Solutions and Teuza.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in stage-agnostic Israeli companies by Teuza.
|
Locked | Locked | Locked | |
|
Wound care products and surgical dressings are developed.
|
Locked | Locked | Locked |
Investor details for Sealantis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sealantis
Investment portfolio details for Sealantis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sealantis
Detailed financials for Sealantis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sealantis Comparisons
Peer comparison for Sealantis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sealantis
Sealantis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Imbed Biosciences, Cresilon, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanotech-based wound care products are developed and provided.
|
|
| Locked | Locked | Locked |
Developer of hemostatic products for wound care
|
|
| Locked | Locked | Locked |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| Locked | Locked | Locked |
Biomaterials and devices for internal wound healing are developed.
|
|
| Locked | Locked | Locked |
Dressing materials and medical devices
|
|
| Locked | Locked | Locked |
Wound-healing therapies for oral surgery and chronic wounds are developed.
|
Detailed competitors of Sealantis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sealantis
Complete news archive for Sealantis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sealantis
Sealantis was founded in 2007 and raised its 1st funding round 8 years after it was founded.
Sealantis is headquartered in Haifa, Israel. It is registered at Haifa, Haifa District, Israel.
Sealantis is a funded company, having raised a total of $3M across 1 funding round to date.
Sealantis was founded in 2007 and is headquartered in Haifa, Israel. Operations center on biotechnology, where an alga-mimetic adhesive platform is developed to replicate algaes underwater adhesion processes. This technology supports applications in surgical procedures, wound management, and controlled drug delivery mechanisms. The focus remains on advancing medical adhesion solutions within the health tech sector.
Sealantis's top competitors include Imbed Biosciences, Cresilon and Kane Biotech.
Sealantis has 2 investors. Key investors include Advanced Medical Solutions, and Teuza.